Chris Lau
3
All posts from Chris Lau
Chris Lau in Value Stocks,

June 2017 Highlights

Himax orders will surge as VR and AR take hold:


  1. Exelixis (EXEL) rebounded from around $18 - $20 to $24.64 a share. EXEL was in the doghouse.

$EXEL, Exelixis, Inc. / D

  1. Acadia Pharmaceuticals (ACAD) bottomed at $25. Oversold condition gave way to buying.
  2. Teva Pharma (TEVA) was too cheap below $30.
  3. Sarepta (SRPT) multiple bottom was at $27 - $30. The incoming CEO could lead to Allergan buying SRPT.
  4. Alibaba (BABA) breezed past the $130 PT and closed at ~ $140.
  5. Himax Technology (HIMX) bottomed. The rally through to $8.50 stalled. HIMX is also a DIY Top Idea.

$HIMX, Himax Technologies, Inc. / D

  1. Micron (MU) did not quite close at $35 when it reported earnings. Trading action on MU was covered throughout the week for DIY Investing Subscribers.
  2. Snap Inc. (SNAP) fell below $15. Short SNAP, Long TWTR, Long FB is a viable strategy.
  3. Valeant (VRX) breezed past the PT $15. Thanks, CEO Joe Papa.
  4. $VRX, VALEANT PHARMACEUTICALS INTERNATIONAL / D
  5. Citi (C) was pumping Nvidia (NVDA).
  6. If you had $25,000 for Investing,You would Buy ___- the most popular post in June.
  7. Goldman (GS) is downgrading AMD (AMD). Speculate it is doing so to get a better entry price.
  8. $AMD, Advanced Micro Devices, Inc. / D
  9. Rite Aid (RAD) management fleeced shareholders and bondholders. Well-played. Walgreens (WBA) did a fine job getting this deal through (pending FTC approval).

Looking ahead:

  1. July’s top 3 biotech picks are here. VRX is on the list.
  2. Value Stocks milestone: 700 members.
  3. Post your trading move below. Sign-in now  (via StockTwits, Facebook, Twitter).Like’ this post to <<ping>> all followers.